A detailed history of Aqr Capital Management LLC transactions in Maxcyte, Inc. stock. As of the latest transaction made, Aqr Capital Management LLC holds 12,565 shares of MXCT stock, worth $52,647. This represents 0.0% of its overall portfolio holdings.

Number of Shares
12,565
Previous 13,489 6.85%
Holding current value
$52,647
Previous $52,000 7.69%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$3.68 - $5.06 $3,400 - $4,675
-924 Reduced 6.85%
12,565 $48,000
Q2 2024

Aug 14, 2024

SELL
$3.63 - $5.0 $6,918 - $9,530
-1,906 Reduced 12.38%
13,489 $52,000
Q1 2024

May 15, 2024

SELL
$3.94 - $5.38 $54,840 - $74,884
-13,919 Reduced 47.48%
15,395 $64,000
Q4 2023

Feb 14, 2024

BUY
$2.6 - $5.24 $34,970 - $70,478
13,450 Added 84.78%
29,314 $137,000
Q3 2023

Nov 14, 2023

BUY
$3.02 - $5.1 $47,909 - $80,906
15,864 New
15,864 $49,000

Others Institutions Holding MXCT

About MAXCYTE, INC.


  • Ticker MXCT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 101,724,000
  • Market Cap $426M
  • Description
  • MaxCyte, Inc., a global life sciences company, engages in the discovery, development, and commercialization of next-generation cell therapies. Its products include ExPERT ATx, a static electroporation instrument for small to medium scale transfection; ExPERT STx, a flow electroporation for protein production and drug development, as well as expr...
More about MXCT
Track This Portfolio

Track Aqr Capital Management LLC Portfolio

Follow Aqr Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aqr Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aqr Capital Management LLC with notifications on news.